Northern Light Venture Capital

成立时间：2014-01-01

基本信息：

Northern Light Venture Capital was founded by general partners Feng Deng and Yan Ke on January 1, 2005. Currently it is managed by five Managing Directors. It manages approximately US$ 1.5 billion in committed capital with 4 US$ funds and 4 RMB funds, investing in more than 180 portfolio companies and seed investments to date. NLVC is led by a partnership of accomplished local Chinese and ""returnee"" executives (""returnees"" are those who grew up in mainland China but studied or worked abroad before returning) with significant investing and entrepreneurial accomplishments. Its management team includes Feng Deng, former member of the board at NetScreen (a pioneering IT security firm), Yan Ke, vice President of Netscreen, and Lei Yang, chairman of Vantage Point Venture Partners. NLVC is a China concept venture capital firm focused on early and growth stage opportunities which targets businesses that leverage China’s industrial, economic, or human resources to build exceptional, lasting enterprises in the global economy. NLVC focuses on early and growth stage opportunities in information technology, new media, TMT, clean technologies, consumer service and healthcare. Portfolio companies include Meituan.com, Kaixin001.com, Gogo.com, redbaby.com, MasaMaso.com, and Velo City.

机构画像：

主投领域：

应用技术：

治疗技术
免疫球蛋白型抗体
单克隆抗体
双特异性抗体
抗体药物
检测诊断技术
物理治疗技术
经颅磁刺激技术(tms)
脊髓电刺激技术
药物治疗
靶向治疗

热门标签：

创新药
单克隆抗体
双特异性抗体
细胞治疗

机构动态

肺部神经调控系统开发商Spiro Medical获得6700万美元A轮融资，用于开发哮喘神经调节系统

2026-01-07

2026年1月7日，肺部神经调控系统开发商Spiro Medical获得6700万美元A轮融资，由Andera Partners、Omega Funds和Sherpa Healthcare Partners共同领投，并有HSG（香港）、Supernova Invest（巴黎）、Northern Light Venture Capital（加州门洛帕克）和Hero Inc. Ltd UK（印度Hero Enterprise集团的一部分）加入。融资所得将用于开发专门的PNM系统，并执行美国监管审批所需的临床工作。